Fund moves

Steris (STE): Findlay Park Partners LLP reduced its stake -17K shares

Findlay Park Partners LLP reduced its stake in Steris, per its Q2 2026 13F.

658K
Shares reported · -17K vs prior quarter
1.9%
Disclosed portfolio weight
$138M
Reported value
Holdings as of
Jun 30, 2026
Filed
Aug 12, 2026

What stands out in this filing

  • 674,755 shares in Q1 2026, 657,713 now (−2.5% in share count).
  • Reported at $138M, 1.87% of the portfolio value in this 13F filing.
  • 35 other tracked managers reported the same kind of change for Q2 2026.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

The company's last weighty Form 8-K report up to this date: announced job cuts, closures or a restructuring, 7 days earlier (Aug 5, 2026). The first one after it: signed an important agreement, 60 days later (Oct 11, 2026).

  1. Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 31, 2026, Pierre Boulud was appointed to serve on the Audit Committee of the Board and the Compliance and Technology Committee of the Board.”
  2. InsiderOfficer sold ~$297K of STE shares in the open market
  3. FDAFDA device clearance: AMSCO 700 Steam Sterilizer
  4. CongressDisclosed sale of STE — reported range $1,001 - $15,000
  5. CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
  6. CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
  7. CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
  8. CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
  9. Company filing · Form 8-K · Results, RestructuringAnnounced job cuts, closures or a restructuring, and reported its results“On August 5, 2026, the Company announced a targeted consolidation plan (the “Consolidation Plan”) to consolidate existing manufacturing and distribution for formulated chemistries to a new Center of Excellence in North Carolina.”
  10. InsiderDirector sold ~$957K of STE shares in the open market

What came next

  1. CongressDisclosed sale of STE — reported range $100,001 - $250,000
  2. FDARecall: VERIFY Dual Species Self-Contained Biological Indicator Model/Catalog Number: S3060
  3. FDARecall: VERIFY Biological/Integrator Challenge Pack Model/Catalog Number: LCB007
  4. FDARecall: VERIFY Dual Species Self-Contained Biological Indicator Model/Catalog Number: S3061
  5. FDARecall: VERIFY Biological/Integrator Challenge Pack Model/Catalog Number: LCB006
  6. FDARecall: VERIFY Biological Steam Test Pack Model/Catalog Number: S3065
  7. FDARecall: VERIFY Biological Steam Test Pack Model/Catalog Number: S3069
  8. CongressDisclosed sale of STE — reported range $15,001 - $50,000
  9. FDARecall: RAPICIDE PA Part A High-Level Disinfectant, Model/Catalog Number: ML020116
  10. FDARecall: RAPICIDE PA Part A High-Level Disinfectant, Model/Catalog Number: ML020115
  11. FDARecall: RAPICIDE PA Part A High-Level Disinfectant, Model/Catalog Number: ML020117
  12. FDARecall: HexaVue Focus Integration System, a single, all-in-one system that handles operating room video routing, surgical video integration, and environmental control,…
  13. FDAFDA device clearance: MEDIVATORS™ ADVANTAGE NXT™ Automated Endoscope Reprocessor
  14. Company filing · Form 8-K · Material agreementSigned an important agreement
  15. FDAFDA device clearance: VERIFY RESI-TEST SWAB Protein Detection Indicator
  16. FDAFDA device clearance: V-Pro maX 2 Low Temperature Sterilization System
  17. Company filing · Form 8-K · Results, RestructuringAnnounced job cuts, closures or a restructuring, and reported its results
  18. Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 1 more item)
  19. Insider · 1 personInsiders: 2 sales (~$1.2M)
  20. InsiderCFO sold ~$1.5M of STE shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Steris

For Steris, OQRO holds 7 insider filings (SEC Form 4 or Form 144) and 3 Congress trade reports dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its STE page.

How this filing works

Explore the data

Common questions

What does this filing report about Steris (STE) stock?

Findlay Park Partners LLP reduced its stake in Steris, per its Q2 2026 13F. Now 658K shares, $138M reported value, 1.9% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Jun 30, 2026. Filed: Aug 12, 2026.

What stands out in this filing?

674,755 shares in Q1 2026, 657,713 now (−2.5% in share count). Reported at $138M, 1.87% of the portfolio value in this 13F filing. 35 other tracked managers reported the same kind of change for Q2 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Steris recently?

For Steris, OQRO holds 7 insider filings (SEC Form 4 or Form 144) and 3 Congress trade reports dated in the last 90 days. They are listed on the STE page.

Does this mean STE stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Steris

Everything OQRO holds on this company is on its STE page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data